K Pharma (TSE:4896) Accounts Payable & Accrued Expense : 円8 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is K Pharma Accounts Payable & Accrued Expense?

K Pharma's quarterly accounts payable & accrued expense declined from Sep. 2023 (円181 Mil) to Dec. 2023 (円89 Mil) and declined from Dec. 2023 (円89 Mil) to Mar. 2024 (円8 Mil).

K Pharma's annual accounts payable & accrued expense increased from Dec. 2021 (円3 Mil) to Dec. 2022 (円12 Mil) and increased from Dec. 2022 (円12 Mil) to Dec. 2023 (円89 Mil).

K Pharma Accounts Payable & Accrued Expense Historical Data

The historical data trend for K Pharma's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Accounts Payable & Accrued Expense Chart

K Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

3.16

11.94

88.65

K Pharma Quarterly Data
	Dec21	Dec22	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			11.94	310.67	180.95	88.65	8.22

K Pharma Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

K Pharma (TSE:4896) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032

Website

https://en.kpharma.co.jp

K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines